These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8139757)

  • 1. Inhibitory effects of tryptamine on tolbutamide-induced hypoglycemia in mice: mediation by 5-HT receptors.
    Sugimoto Y; Yamada J; Kimura I; Watanabe Y; Horisaka K
    Neurochem Res; 1994 Jan; 19(1):19-22. PubMed ID: 8139757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypoglycemic effects of tryptamine in mice: mediation by 5-HT receptors.
    Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K
    Eur J Pharmacol; 1988 Nov; 156(2):299-301. PubMed ID: 3240774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of serotonin receptors by tryptamine induces hyperinsulinemia in mice.
    Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K
    Eur J Pharmacol; 1990 Jun; 181(3):319-22. PubMed ID: 2200694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-induced hypoglycemia and increased serum insulin levels in mice.
    Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K
    Life Sci; 1989; 45(20):1931-6. PubMed ID: 2689822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally administered serotonin induces hyperglucagonemia in mice.
    Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Takeuchi N; Horisaka K
    Life Sci; 1993; 52(23):1845-9. PubMed ID: 8502121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglucagonemia induced in mice by tryptamine: involvement of the peripheral 5-HT2 receptors.
    Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Takeuchi N; Horisaka K
    Eur J Pharmacol; 1992 Jun; 216(2):307-10. PubMed ID: 1397014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
    Yamada J; Sugimoto Y; Yoshikawa T
    Eur J Pharmacol; 1998 Oct; 359(2-3):185-90. PubMed ID: 9832390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evidence for the involvement of the 5-HT1A receptor in 5-HT syndrome induced in mice by tryptamine.
    Yamada J; Sugimoto Y; Horisaka K
    Jpn J Pharmacol; 1989 Nov; 51(3):421-4. PubMed ID: 2622095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig.
    Villalón CM; den Boer MO; Heiligers JP; Saxena PR
    Br J Pharmacol; 1991 Jan; 102(1):107-12. PubMed ID: 2043916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological analysis of the variation in behavioural responses to tryptamine in five strains of mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1987 Aug; 140(3):323-30. PubMed ID: 3653248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin receptor subtypes involved in modulation of electrical acupuncture.
    Takagi J; Yonehara N
    Jpn J Pharmacol; 1998 Dec; 78(4):511-4. PubMed ID: 9920210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tryptamine on plasma glucagon levels in mice.
    Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Horisaka K
    Neurochem Res; 1994 Jan; 19(1):15-8. PubMed ID: 7908128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):484-92. PubMed ID: 3137478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peripheral serotonin2 receptors induces hypothermia in mice.
    Sugimoto Y; Yamada J; Horisaka K
    Life Sci; 1991; 48(5):419-23. PubMed ID: 1992284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
    Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
    Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of serotonin 5-HT1, 5-HT2, and 5-HT3 receptor antagonists on the prolactin response to restraint and ether stress.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Sep; 56(3):371-7. PubMed ID: 1436375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
    Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.